Enter your login e-mail to the account
Search
- Články uverejnené v časopise Via Practica v roku 2005
(1/2006, attachment ) - Classification of dyslipoproteinaemias: Part II – Secondary dyslipoproteinaemias
MUDr. Ľubomíra Fábryová, PhD.
(6/2009, Topic of the year ) - The choice of antidiabetic medications with regard to metabolic syndrome
doc. MUDr. Alena Šmahelová, PhD.
(11/2009, Review articles ) - The role of fibrates in a statin world
MUDr. Ľubomíra Fábryová, PhD.
(11/2009, Topic of the year ) - Svetový deň diabetu: vážne upozornenia
Magdaléna Žiaková
(11/2009, Information & comments ) - Evolokumab pro léčbu familiární hypercholesterolémie
prof. MUDr. Vladimír Bláha, CSc.
(4/2018, Drugs & drug classes ) - Current scientific knowledge about NAFLD/MAFLD during the COVID-19 pandemic and the benefits of essential phospholipids in the treatment of hepatic steatosis
doc. MUDr. Peter Minárik, PhD., MSc, prof. PharmDr. Ján Kyselovič, CSc., prof. MUDr. Ivan Schréter, CSc., doc. MUDr. Zuzana Paraličová, PhD., prof. MUDr. Peter Jarčuška, PhD.
(4/2022, Review articles ) - Future of hypolipidemic therapy
MUDr. Fábryová Ľubomíra, PhD.
(5/2010, Topic of the year ) - Combined hypolipidemic therapy in current clinical practice
MUDr. Ľubomíra Fábryová, PhD.
(6/2014, Review articles ) - PROBIOTICS IN AMBULATORY PRACTICE
MUDr. Juraj Mokrý, PhD.
(4/2007, Topic ) - CHRONIC HEART FAILURE AND DIABETES MELLITUS
prof. MUDr. Jindřich Špinar, CSc., FESC., prof. MUDr. Jiří Vítovec, CSc.
(1/2005, Topic ) - Physical exercise – mandatory part of complex dyslipidemia managment
prof. MUDr. Dušan Meško, PhD.
(7-8/2009, Topic of the year ) - Retardované mononitráty v klinické praxi
prof. MUDr. Jindřich Špinar, CSc., FESC., prof. MUDr. Jiří Vítovec, CSc.
(1/2005, Spectrum ) - Adiposopathic dyslipidaemia
MUDr. Ľubomíra Fábryová, PhD., MPH
(6/2021, Topic of the year ) - PREVENTION OF CARDIOVASCULAR DISEASES IN POSTMENOPAUSAL WOMEN
prof. MUDr. Miroslav Borovský, CSc., MUDr. Michaela Lattáková, PhD.
(4-5/2008, Topic ) - MANAGEMENT OF ATHEROGENIC DYSLIPIDAEMIA IN THE METABOLIC SYNDROME
MUDr. Ľubomíra Fábryová
(S4/2007, Supplement ) - Metabolic changes after bariatric surgery
MUDr. Pavol Holéczy, CSc., Mgr. Marek Bužga, PhD.
(2/2016, Topic of the year ) - MANAGEMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH METABOLIC SYNDROME
prof. MUDr. Daniel Pella, PhD., doc. MUDr. Viola Mechírová, CSc.
(S4/2007, Supplement ) - Pán doktor, príďte! Zápisky lekára po 100 rokoch
MUDr. Jozef Jakuš
(4/2005, Relax ) - PROBLEMS WITH PREVENTION AND DIAGNOSTICS OF DIABETES MELLITUS TYPE 2
doc. MUDr. Eva Valovičová, CSc.
(1/2005, Topic ) - XV. medzinárodné sympózium – Drugs Affecting Lipid Metabolism – DALM
MUDr. Ľubomíra Fábryová
(1/2005, Spectrum ) - ALCOHOL AND DIABETES MELLITUS
MUDr. Jiří Mudra, doc. MUDr. Zdeněk Rušavý
(1/2005, Topic ) - POSSIBILITIES OF DIAGNOSIS AND TREATMENT OF LIPIDS DISORDERS IN AMBULANCE OF GENERAL PRACTITIONER
MUDr. Ľubomíra Fábryová
(6/2005, clearly ) - Hypolipidemic treatment of patients with nonalcoholic fatty liver disease
doc. MUDr. Peter Jarčuška, PhD., MUDr. Martin Janičko, MUDr. Eduard Veseliny, MUDr. Ján Fedačko, MUDr. Božena Nováková, prof. MUDr. Daniel Pella, CSc.
(6/2010, Topic of the year ) - Significance of combined hypolipidemic therapy for patients with metabolic syndrome
MUDr. Renáta Palmajová
(3/2010, Original articles & case reports ) - STATINS – DO THEY HAVE DOMINANT POSITION IN CARDIOVASCULAR PREVENTION? LIPID LOWERING AND PLEIOTROPIC EFFECTS OF STATINS
doc. MUDr. Daniel Pella, PhD., MUDr. Viola Vargová, PhD., MUDr. Ján Fedačko, MUDr. Richard Raši
(1/2007, clearly ) - PREVENTION OF THE ISCHEMIC HEART DISEASE
MUDr. Milan Luknár, MUDr. Branislav Líška
(4/2005, Topic ) - Molecular genetics of dyslipidemy
Ing. Jaroslav A. Hubáček, CSc., MUDr. Michal Vrablík, PhD.
(4/2009, Topic of the year ) - Cardiovascular risk in diabetics
prof. MUDr. Miroslav Souček, CSc., MUDr. Petr Žák
(6/2015, Review articles ) - Obesity as a cause of cardio-nephro-hepato-metabolic diseases
doc. MUDr. Ľubomíra Fábryová, PhD., MPH
(2/2023, Topic of the year ) - Statins and ezetimibe – current position in the treatment of dyslipidaemias (cardiovascular prevention)
doc. MUDr. Jana Sirotiaková, PhD., RNDr. Miriam Zagyiová
(10/2009, Topic of the year ) - Classification of dyslipoproteinaemias: Part I – Primary dyslipoproteinaemias
MUDr. Ľubomíra Fábryová, PhD.
(5/2009, Topic of the year ) - News in ESC/EAS recommendations 2019 for dyslipidemia management
MUDr. Ľubomíra Fábryová, PhD.
(6/2019, Review articles ) - THE ENDOCRINE FUNCTION OF ADIPOSE TISSUE
MUDr. Barbara Ukropcová, Mgr. Jozef Ukropec, PhD., prof. MUDr. Iwar Klimeš, DrSc., prof. MUDr. Ivan Tkáč, PhD.
(3/2008, Topic )
- The effect of antidepressants on serum lipid parameters
MUDr. Dagmar Breznoščáková, Mgr. Martina Chylová, PhD., Klára Maceková
(4/2011, Original articles & case reports ) - The Risk of the Refeeding Syndrome in Mental Anorexia
MUDr. Miroslava Navrátilová
(4/2002, Review articles ) - Neurobiology circadian rhythms and clinical applications
MUDr. Pavel Černák, PhD.
(4/2009, Review articles ) - Atypical antipsychotics and diabetes mellitus
doc. MUDr. Roman Jirák, CSc., doc. MUDr. Miroslav Zeman, CSc.
(1/2013, Review articles ) - Metabolic syndrome in the context of psychiatric disorders and psychotropic treatment
MUDr. Jozef Dragašek, PhD.
(1/2014, Review articles ) - Ziprasidone treatment and metabolic parameters changes
MUDr. Jozef Dragašek, PhD., MUDr. Simona Líšková
(2/2011, Original articles & case reports )
- X-viazaná adrenoleukodystrofia – najčastejšia dedičná metabolická porucha peroxizómov
doc. MUDr. Ján Chandoga, CSc., RNDr. Robert Petrovič, Mgr. Ján Futas, MUDr. Darina Ďurovčíková, CSc., MUDr. Juraj Štofko, PhD., MUDr. Stanislav Jančo, CSc., MUDr. Mária Brezinová, prof. MUDr. Peter Turčáni, PhD.
(2/2006, Main topic ) - A rare lysosomal disease – Niemann-Pick disease type C
doc. MUDr. Pavol Sýkora, CSc., MUDr. Miriam Kolníková, RNDr. Ivan Chalupa, PhD.
(6/2009, Video case reports ) - Stroke in diabetic patients
doc. MUDr. Jaromír Chlumský, Ph.D., prof. MUDr. Jindra Perušičová, DrSc., prof. MUDr. Milan Kvapil, CSc.
(1/2010, From the boundary of neurology ) - Rhabdomyolysis
doc. MUDr. Peter Špalek, PhD.
(4/2012, Main topic ) - Statin myopathy
Prof. MUDr. Josef Bednařík, CSc., MUDr. Eva Vlčková, Ph.D., MUDr. Tomáš Horák
(1/2017, Main topic ) - Epilepsy and metabolic syndrome X
MUDr. Irena Novotná
(3/2011, Review articles )
- Metabolic syndrome in children and its diagnostic problems
prof. MUDr. László Kovács, DrSc., MPH, doc. MUDr. Ľudmila Košťálová, CSc., mim. prof., MUDr. Zuzana Pribilincová, CSc., MUDr. Anna Hlavatá, PhD., MUDr. Eva Vitáriušová, PhD., MUDr. Katarína Babinská, ml.
(3/2011, Original articles ) - LIPIDS IN CHILDHOOD NUTRITION
MUDr. Pavel Frühauf, CSc.
(1/2008, Review articles ) - Obesity in children and adolescents
MUDr. Eva Vitáriušová, PhD., MUDr. Katarína Prochotská, PhD., doc. MUDr. Ľudmila Košťálová, CSc., MUDr. Anna Hlavatá, PhD., MPH, MUDr. Zuzana Priblincová, PhD., prof. MUDr. László Kovács, DrSc., MPH
(3/2017, Review articles )
- Androgen deprivation therapy of prostate cancer and cardiovascular morbidity
MUDr. Otakar Čapoun, Ph.D., FEBU
(4/2019, Review articles )
- New methods of nutritional support in cancer cachexia
prof. MUDr. Zdeněk Zadák, CSc., MUDr. Radomír Hyšpler, Ph.D., RNDr. Alena Tichá, Ph.D., MUDr. Robert Hromádka
(2/2010, Review articles ) - Cancer cachexia in the perspective of the new definition
MUDr. Andrea Škripeková
(2/2012, Review articles ) - View of the cancer patient with cachexia syndrome
MUDr. Andrea Škripeková
(5/2010, Original articles & case reports )
- STATÍNY – MAJÚ DOMINANTNÉ MIESTO V KARDIOVASKULÁRNEJ PREVENCII? LIPIDY ZNIŽUJÚCE A PLEIOTROPNÉ ÚČINKY STATÍNOV
doc. MUDr. Daniel Pella, PhD.
(2/2007, clearly )
- Biological effects of Chlorella pyrenoidosa and young barley leaves with possible use in the prevention of civilization diseases
Doc. RNDr. Peter Kubatka, PhD.
(1/2018, Phytotherapy ) - What can statins do in the management of cardiovascular deseases?
MUDr. Marta Filková, prof. MUDr. Ján Murín, CSc.,, MUDr. Miroslav Pernický
(1/2013, Current pharmacotherapy ) - Dyslipidémie ako rizikový faktor kardiovaskulárnych ochorení: dôraz na familiárnu hypercholesterolémiu, jej včasnú diagnostiku a terapiu
Doc. PharmDr. Adriana Duriš Adameová, PhD.
(2/2018, Current pharmacotherapy )
- Statins and ezetimibe – current position in the treatment of dyslipidaemias (cardiovascular prevention)
doc. MUDr. Jana Sirotiaková, PhD., RNDr. Miriam Zagyiová
(4/2010, Drugs & drug classes ) - Significance of hematological markers on cardiovascular risk
MUDr. Marek Kučera, PhD., MHA, MPH
(2/2019, Original articles & Case reports ) - Arterial hypertension in diabetic patients
doc. MUDr. Boris Krahulec, CSc., MUDr. Daša Mesárošová, PhD., MUDr. Eva Hirnerová, PhD.
(2/2013, Main topic )